Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 23, 2021

SELL
$39.04 - $64.6 $156,160 - $258,399
-4,000 Closed
0 $0
Q4 2020

Jan 25, 2021

SELL
$42.46 - $56.58 $280,236 - $373,428
-6,600 Reduced 62.26%
4,000 $184,000
Q2 2020

Jul 23, 2020

SELL
$17.62 - $58.71 $35,240 - $117,420
-2,000 Reduced 15.87%
10,600 $561,000
Q1 2020

Apr 23, 2020

BUY
$12.26 - $41.14 $50,266 - $168,674
4,100 Added 48.24%
12,600 $281,000
Q3 2019

Oct 21, 2019

BUY
$7.04 - $11.77 $48,576 - $81,213
6,900 Added 431.25%
8,500 $59,000
Q2 2019

Jul 25, 2019

BUY
$8.99 - $11.79 $14,384 - $18,864
1,600 New
1,600 $17,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $10.6M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.